Editor-in-Chief’s Commentary: Collaborate to Innovate Stephen P. Spielberg Commentary 30 December 2014 Pages: 132 - 133
Clinical Data for Informed Medication Use in Pregnancy: Strengths, Limitations, Gaps, and a Need to Continue Moving Forward David B. ClemowLode DewulfAndreas M. Kogelnik Special Populations: Womenʼs Health 30 December 2014 Pages: 134 - 144
A Proposed Framework to Address Needs of Clinical Data for Informed Medication Use in Pregnancy David B. ClemowLode DewulfJ. Stephen Mikita Special Populations 30 December 2014 Pages: 145 - 154
Analysis of Medical Information Responses to Unsolicited Health Care Worker Inquiries Submitted via Sales Representatives or Customers Directly Robert J. FuentesRana KimGreg Susla Medical Information 30 December 2014 Pages: 155 - 161
Essential Medication Information for Patients: Ensuring Access Bryon M. PearsallRichardae AraojoDenise Hinton Medical Information 30 December 2014 Pages: 162 - 164
Prevalence and Therapeutic Classifications of FDA-Approved Prescription Drugs With Boxed Warnings Christine M. ChengColleen DeLizzaJoan Kapusnik-Uner Safety 30 December 2014 Pages: 165 - 172
A Data-Driven Approach to Risk-Based Source Data Verification Elizabeth NielsenDeAnn HyderChao Deng Safety 30 December 2014 Pages: 173 - 180
Evaluation of Assay Sensitivity and the Concentration-Effect Relationship of Moxifloxacin in a QT/QTc Study in Japan Masanari ShiramotoHinako UchimaruShin Irie Safety 30 December 2014 Pages: 181 - 189
Pharmacovigilance Legislation: The Impact of What Is Happening in Europe Miranda Z. Dollen Safety 30 December 2014 Pages: 190 - 199
Optimizing Expedited Safety Reporting for Drugs and Biologics Subject to an Investigational New Drug Application Patrick ArchdeaconCheryl GrandinettiJudith M. Kramer Safety Open access 30 December 2014 Pages: 200 - 207
On the Importance in Clinical Trials That Critical Regions for Comparing 2 Independent Proportions Must Be Barnard Convex Sets Félix Almendra-AraoDavid Sotres-Ramos Biostatistics 30 December 2014 Pages: 208 - 212
A Continual Reassessment Method With Cohort Size Adaptation Based on Bayesian Posterior Probabilities in Phase I Dose-Finding Studies Tomoyuki KakizumeSatoshi Morita Biostatistics 30 December 2014 Pages: 213 - 219
Treatment and Outcomes of Community-Acquired Pneumonia in Hospitalized Patients: The Case of Jimma University Specialized Hospital Osman Mohammed AhmedtahaAlemshet YamiMohammed Adem Mohammed Global Health 30 December 2014 Pages: 220 - 225
Cross-regional Pharmaceutical Technology Transfer in China: Patterns and Proposed Investment Strategies Jingyun NiJiachen XuYitao Wang Global Health 30 December 2014 Pages: 226 - 235
Evolving Global Regulatory Science Through the Voluntary Submission of Data: A 2013 Assessment Elizabeth Gribble WalkerMartha BrumfieldRaymond Woosley Global Health 30 December 2014 Pages: 236 - 245
Further Understanding of the International Index of Erectile Function at 15+ Years: Confirmatory Factor Analysis and Multidimensional Scaling Andrew G. BushmakinJoseph C. CappelleriVera J. Stecher Global Health 30 December 2014 Pages: 246 - 254
The Effectiveness of the Summary of Product Characteristics (SmPC) and Recommendations for Improvement David K. RaynorPeter De VeeneDavid Bryant Regulatory Science 30 December 2014 Pages: 255 - 265
Evolving Role of Pharmacists in Care Coordination: A National Survey Jessica CherianKrishna R. PatelJack Timko Health Care Delivery 30 December 2014 Pages: 266 - 271
Circadian Variation and Baseline Definition in Parallel-Group Thorough QT Studies David Hoffman Health Care Delivery 30 December 2014 Pages: 272 - 286
Reply to Letter to the Editor: Local Evaluation and Blinded Central Review Comparison a Victim of Meta-analysis Shortcomings Jenny J. ZhangHuanyu ChenRajeshwari Sridhara Response 30 December 2014 Pages: NP1 - NP2
